ARKG vs EWY
ARK Genomic Revolution ETF vs iShares MSCI South Korea ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
EWY—
iShares MSCI South Korea ETF
South Korean large and mid-cap equities.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | EWY |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Holdings data unavailable for ARKG.
EWY top holdings
Holdings data unavailable for EWY.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About EWY
EWY (iShares MSCI South Korea ETF) is South Korean large and mid-cap equities.